4F-MDMB K2 INFUSED PAPER - AN OVERVIEW

(b) If the executive commissioner establishes a plan below this subchapter, the commissioner shall publish a report not later than January one of each odd-numbered yr to the professional medical usefulness of the use of tetrahydrocannabinols and their derivatives and every other health-related conclusions of the study application.(e) This area will